The JNPMEDI global team will be exhibiting its ‘Maven Clinical Cloud’ solution in the DIA to speed up its entry into the global market. DIA is a place to build a network by sharing the latest trends and knowledge about drug development and regulation with experts from around the globe.
Through this event, JNPMEDI plans to increase brand awareness in the global marketplace and explore opportunities for cooperation with foreign partners by showcasing its technology, the ‘Maven Clinical Cloud’ solution.
In addition, to grasp the latest trends in drug development and regulations, and to strengthen the research and development capabilities of its solutions based on this knowledge, JNPMEDI has decided to participate in various sessions and programs.
Jingon Kim, Director overseeing business development at JNPMEDI, stated, "Our participation in the independent booth at DIA will serve as a stepping stone for us to leap into a competitive player in the global market." He added, "As a specialized company in data management solutions for conducting global clinical trials, we plan to actively engage in promotional and marketing activities to enhance our market visibility and expand collaboration opportunities with international partners."
The JNPMEDI global team will be exhibiting its ‘Maven Clinical Cloud’ solution in the DIA to speed up its entry into the global market. DIA is a place to build a network by sharing the latest trends and knowledge about drug development and regulation with experts from around the globe.
Through this event, JNPMEDI plans to increase brand awareness in the global marketplace and explore opportunities for cooperation with foreign partners by showcasing its technology, the ‘Maven Clinical Cloud’ solution.
In addition, to grasp the latest trends in drug development and regulations, and to strengthen the research and development capabilities of its solutions based on this knowledge, JNPMEDI has decided to participate in various sessions and programs.
Jingon Kim, Director overseeing business development at JNPMEDI, stated, "Our participation in the independent booth at DIA will serve as a stepping stone for us to leap into a competitive player in the global market." He added, "As a specialized company in data management solutions for conducting global clinical trials, we plan to actively engage in promotional and marketing activities to enhance our market visibility and expand collaboration opportunities with international partners."